FMD K&L Inc. is a contract research organization (CRO) offering end-to-end data management, biostatistics, statistical programming and medical writing services as well as CDISC compliant eSubmission services to the pharmaceutical, biotechnology and medical device industries worldwide. Noted for their use of scientific principles, innovative approaches, and streamlined processes optimized for regulatory compliance, K&L takes pride in their ability to provide high quality deliverables on time and within budget. K&L is committed to accuracy, precision and continuous improvement throughout the development life cycle. Their expertise in analyzing and compiling clinical data into a compliant FDA submission is a proven process that has resulted in many faster drug approvals.
